Tenaya Therapeutics Stock Forecast for 2023 - 2025 - 2030

Updated on 05/12/2024

Stock Rating
2
Price Target
$18.00
Consensus
Outperform
Upside
328.57%
Analysts
0
Stock Rating
2
Upside
328.57%
Analysts
0
Price Target
$18.00

Tenaya Therapeutics Stock Forecast and Price Target

According to experts, who recently provided their 2024 price targets for Tenaya Therapeutics, the average price target is $18.00, with a high estimate of $40.00 and a low estimate of $7.00. That is a potential upside of approximately 328.57% from the last closing price of $4.20 on May, 2024.

$18.00

328.57% Upside

Buy
Buy

Tenaya Therapeutics Fair Value Forecast for 2023 - 2025 - 2030

In the last three years, Tenaya Therapeutics's Price has grown by 100.00%, rising from $0.00 to $0.00. For the next year, analysts predict that Fair Value will reach $0.00 – an increase of 100.00%. Over the next six years, experts believe that Tenaya Therapeutics's Fair Value will grow at a rate of 100.00%.

2025 Fair Value Forecast
$0.00
2026 Fair Value Forecast
$0.00
2027 Fair Value Forecast
$0.00
2028 Fair Value Forecast
$0.00
2029 Fair Value Forecast
$0.00
2030 Fair Value Forecast
$0.00

Tenaya Therapeutics Revenue Forecast for 2023 - 2025 - 2030

Tenaya Therapeutics Dividend per Share Forecast for 2023 - 2025 - 2030

Tenaya Therapeutics Free Cash Flow Forecast for 2023 - 2025 - 2030

Tenaya Therapeutics EBITDA Forecast for 2023 - 2025 - 2030

Tenaya Therapeutics's EBITDA has seen growth In the last three years, going from $-36.43M to $-122.51M – a gain of 236.29% The next year, 0 experts forecast that Tenaya Therapeutics's EBITDA will decrease by 30.66%, reaching $-84.95M. In 2030, professionals predict that Tenaya Therapeutics's EBITDA will decrease by 21.96%, reaching $-95.61M.

2024 EBITDA Forecast
$-84952517.67
2025 EBITDA Forecast
$-84978003.42
2026 EBITDA Forecast
$-96716298.29
2027 EBITDA Forecast
$-107045598.95
2028 EBITDA Forecast
$-99259815.72
2029 EBITDA Forecast
$-94644234.29
2030 EBITDA Forecast
$-95612760.29

Tenaya Therapeutics EBIT Forecast for 2023 - 2025 - 2030

In the last three years, EBIT for Tenaya Therapeutics has grown by 237.16%, going from $-38.91M to $-131.19M. According to the 0 analysts polled, in the next year, Tenaya Therapeutics's EBIT will fall by 30.95%, reaching $-90.59M. By 2030, professionals believe that Tenaya Therapeutics's EBIT will have decreased by 22.58%, falling to $-101.56M.

2024 EBIT Forecast
$-90586695.00
2025 EBIT Forecast
$-90142820.19
2026 EBIT Forecast
$-102480367.52
2027 EBIT Forecast
$-113845440.28
2028 EBIT Forecast
$-105675132.51
2029 EBIT Forecast
$-100641473.70
2030 EBIT Forecast
$-101564020.54

Tenaya Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last three years, Tenaya Therapeutics's EPS has grown by 100.00%, rising from $-4.10 to $0.00. For the next year, analysts predict that EPS will reach $0.00 – an increase of 100.00%. Over the next six years, experts believe that Tenaya Therapeutics's EPS will grow at a rate of 100.00%.

2025 EPS Forecast
$0.00
2026 EPS Forecast
$0.00
2027 EPS Forecast
$0.00
2028 EPS Forecast
$0.00
2029 EPS Forecast
$0.00
2030 EPS Forecast
$0.00